[
    [
        {
            "time": "",
            "original_text": "白雲山(600332.SH)子公司收到关于夏桑菊顆粒、安神补脑液等42个药品的药品再注册批件",
            "features": {
                "keywords": [
                    "白雲山",
                    "子公司",
                    "夏桑菊顆粒",
                    "安神补脑液",
                    "药品再注册批件"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山(600332.SH)子公司收到关于夏桑菊顆粒、安神补脑液等42个药品的药品再注册批件",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 9
            }
        }
    ]
]